Spironolactone for Pulmonary Arterial Hypertension | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Spironolactone for Pulmonary Arterial Hypertension	lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder	Recruiting	Phase 2	2026-10-08		NCT01712620

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Medstar Health Research Institute	52
National Heart, Lung, and Blood Institute (NHLBI)	791
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	617
National Institutes of Health Clinical Center (CC)	42
New England Medical Center, Tufts University School of Medicine	1
University of Maryland, Baltimore	198
University of Pennsylvania	502

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
National Institutes of Health Clinical Center	Bethesda	United States	800